Table: Aska Pharmaceutical -9-MTH group results

ASKA Pharmaceutical Holdings

04/02/2016 06:00

Feb 4 (Reuters)-  
             Aska Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 9 months ended      9 months ended       Year to  
                Dec 31, 2015        Dec 31, 2014     Mar 31, 2016  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             33.53               33.72            44.00     
                 (-0.6 pct)          (+9.2 pct)       (+2.5 pct)   
  Operating          1.55                1.89           800 mln    
                 (-17.9 pct)         (+12.0 pct)      (-43.9 pct)  
  Recurring          1.84                2.11             1.00     
                 (-13.0 pct)         (+8.3 pct)       (-41.9 pct)  
  Net                1.08                1.48           600 mln    
                 (-27.1 pct)         (+15.7 pct)      (-49.7 pct)  
  EPS             38.75 yen           53.26 yen        21.53 yen   
  Ann Div                             14.00 yen        14.00 yen   
  -Q2 div         7.00 yen            7.00 yen                     
  -Q4 div                             7.00 yen         7.00 yen    
   
  NOTE - Aska Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4514.T 
  ((Tokyo Headline News Desk +813 6441 1812))